Prostate Cancer

PSA Testing Not Recommended for Prostate Cancer Screening

PSA Testing Not Recommended for Prostate Cancer Screening

Odds of choosing screening up for men with family history, African descent, low socioeconomic status.

PSA Level 3 Months After Radiation Treatment May Predict Outcome

PSA Level 3 Months After Radiation Treatment May Predict Outcome

Findings for men with intermediate- and high-risk prostate cancer

Screening for Prostate Cancer: USPSTF Recommendation Statement

Screening for Prostate Cancer: USPSTF Recommendation Statement

By

The USPSTF has updated its 2012 recommendations on prostate-specific antigen (PSA)-based screening for prostate cancer.

Prostate-specific antigen screening helps prostate cancer detection

Prostate-specific antigen screening helps prostate cancer detection

By

Prostate cancer was diagnosed more frequently in men who underwent single prostate-specific antigen screening than in those who did not, but mortality was unaffected.

Aggressive treatment not beneficial for metastatic prostate cancer

Aggressive treatment not beneficial for metastatic prostate cancer

For men with metastatic prostate cancer, aggressive therapy has no significant advantage over conservative androgen deprivation only treatments.

Prostate cancer recurrence linked to metabolic syndrome, obesity

Prostate cancer recurrence linked to metabolic syndrome, obesity

A positive correlation between increased BMI and risk of prostate cancer recurrence was observed in patients undergoing radical prostatectomy.

Clinical tool may help in prostate cancer screenings

Clinical tool may help in prostate cancer screenings

By

Polygenic hazard scores were developed to help predict the age of onset of prostate cancer.

Surgery may not improve outcomes in early-stage prostate cancer

Surgery may not improve outcomes in early-stage prostate cancer

A 20-year study found that patients with early-stage prostate cancer who have surgery to remove their tumor do not live longer than those who receive no treatment.

USPSTF recommends individualized approach to prostate cancer screening

USPSTF recommends individualized approach to prostate cancer screening

By

The USPSTF recommends that prostate cancer screenings should be an individual decision.

Antiandrogen therapy improves long-term survival after prostate cancer returns

Antiandrogen therapy improves long-term survival after prostate cancer returns

Antiandrogen therapy with daily bicalutamide to salvage radiation therapy resulted in significantly higher rates of long-term overall survival.

Are prostate biopsies linked to the spread of cancerous cells?

Are prostate biopsies linked to the spread of cancerous cells?

Cases of prostate biopsies resulting in the spread of cancerous cells are rare.

Is vasectomy linked to risk of prostate cancer?

Is vasectomy linked to risk of prostate cancer?

By

Vasectomy can continue to be a safe method of contraception in men.

Risk of Alzheimer dementia after androgen deprivation therapy

Risk of Alzheimer dementia after androgen deprivation therapy

By

A recent cohort study evaluated the risk of developing Alzheimer dementia after ADT in 16,888 men with prostate cancer, 14.2% of whom were treated with ADT.

Diagnostic factors help patients avoid confirmatory prostate biopsy

Diagnostic factors help patients avoid confirmatory prostate biopsy

The analysis of diagnostic characteristics may predict the result of a confirmatory biopsy.

Prostate cancer treatment linked to Alzheimer's risk

Prostate cancer treatment linked to Alzheimer's risk

By

Patients treated with androgen deprivation therapy had a 1.88-times increased rate of developing Alzheimer's disease.

Active surveillance of low-risk prostate cancer patients may not be efficient

Active surveillance of low-risk prostate cancer patients may not be efficient

New research suggests that men with low-risk prostate cancer who undergo choose watchful waiting may not receive timely treatment when compared to those undergoing active treatment.

Reduction in number of men screened for and diagnosed with prostate cancer

Reduction in number of men screened for and diagnosed with prostate cancer

In the United States, the rate of prostate cancer screening is down, and the number of men diagnosed with the disease has also dropped.

Active surveillance 
encouraged for prostate cancer screening

Active surveillance 
encouraged for prostate cancer screening

By

Men should regularly be screened for prostate cancer, the leading cause of cancer death for men in the United States.

More radiation does not increase survival in low-risk prostate cancer

More radiation does not increase survival in low-risk prostate cancer

Higher doses of radiation does not increase survival rates in low-risk prostate cancer.

Targeted PSA screening prevents overdiagnosis, overtreatment

Targeted PSA screening prevents overdiagnosis, overtreatment

By

More targeted efforts needed for prostate-specific antigen screening.

Radiation, hormone therapy for prostate cancer

Radiation, hormone therapy for prostate cancer

By

Combination radiation and hormone therapy is more effective than hormone therapy alone for the treatment of prostate cancer.

Primary care after PCa

Primary care after PCa

PCPs should encourage physical activity, smoking cessation, and a healthy diet for PCa survivors.

New imaging methods better for prostate CA detection

New imaging methods better for prostate CA detection

Multiparametric magnetic resonance imaging reported high accuracy in diagnosing low-risk prostate cancers.

Prostate cancer care measures vary by region

Prostate cancer care measures vary by region

Low adherence rates for prostate cancer care may be target for future quality improvements.

Prostatectomy cuts mortality in early prostate CA

Prostatectomy cuts mortality in early prostate CA

Risk of long-term mortality is lower compared with watchful waiting.

Melatonin linked to lower prostate CA risk

Melatonin linked to lower prostate CA risk

Risk for advanced prostate cancer was 75% lower in men with high levels of 6-sulfatoxymelatonin -- a measure of melatonin breakdown in urine.

Baseline inflammation lowers prostate cancer risk on repeat biopsy

Baseline inflammation lowers prostate cancer risk on repeat biopsy

Even after adjustment, acute, chronic inflammation linked to lower PCa risk at two-year repeat biopsy.

Prostate biopsy causes anxiety even when negative

Prostate biopsy causes anxiety even when negative

Potential psychological harm associated with biopsy even in absence of cancer diagnosis

Coffee protective against prostate CA recurrence

Coffee protective against prostate CA recurrence

Drinking coffee may lower the risk for prostate cancer recurrence and disease progression.

Men don't rely on prostate-screen decision aids

Men don't rely on prostate-screen decision aids

By

Aids help men make more informed choices regarding PSA screening, but did not affect actual screening rates.

Sign Up for Free e-newsletters